Litcius/Paper detail

Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green

Shuhei Okuyama, Daiki Fujimura, Fuyuki Inagaki, Ryuhei Okada, Yasuhiro Maruoka, Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi

2021Cancer Diagnosis & Prognosis18 citationsDOIOpen Access PDF

Abstract

Background/Aim: Near-infrared photoimmuno-therapy (NIR-PIT) is a newly approved cancer phototherapy. We aim to confirm whether a clinically approved camera for indocyanine green (ICG) could monitor IR700 fluorescence in real time during exposure to therapeutic NIR light. Materials and Methods: An NIR camera, LIGHTVISION, designed to image ICG fluorescence, was used. A431-GFP/luc tumor-bearing mice were exposed to therapeutic NIR light and real-time fluorescence imaging (RT-FI) was obtained and measured with LIGHTVISION. Bioluminescence imaging (BLI) was performed to confirm cell death. Results: . Correlation between BLI and IR700 fluorescence loss showed that loss of fluorescence was associated with increased cell death. Conclusion: The efficacy of NIR-PIT could be monitored non-invasively and in real-time using weak fluorescence at wavelengths much longer than the peak fluorescence of IR700. This technique can achieve precise light dosimetry that allows us to decide on the optimal exposure.

Topics & Concepts

Indocyanine greenFluorescenceFluorescence-lifetime imaging microscopyPhotodynamic therapyNuclear medicineChemistryMedicinePathologyOpticsPhysicsOrganic chemistryPhotodynamic Therapy Research StudiesNanoplatforms for cancer theranosticsCancer Research and Treatments
Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green | Litcius